About 75% of patients between the ages of 15 and 55 benefit from ketamine infusion therapy.
Of the 13-14 million people who seek treatment for depression each year, 30-40% will not improve with standard antidepressants.
Studies show that ketamine produces long-lasting changes in the brain, reversing the neural damage caused by stress and depression.
Unlike antidepressants that target the brain’s serotonin or noradrenaline pathways, Ketamine acts on the NMDA receptor, a component of the glutamate pathway, which is involved in memory and cognition.
Ketamine infusions have been found to yield results superior to electroconvulsive therapy – an astounding fact!
The positive effects of ketamine have been noted in people who have been resistant to other treatment methods, including antidepressant medications and psychotherapy.
Several studies demonstrate that ketamine reduces depression within six hours, with effects that are equal to or greater than six weeks worth of treatment with other antidepressant medications.
Ketamine goes to work right away, unlike most antidepressants which take weeks – sometimes months – to provide relief.
The National Institute of Mental Health found that ketamine infusions help reduce suicidal thoughts independently of treating depression or anxiety.
Yale and National Institute of Health researchers say ketamine restores synaptic connections in the brain.